Pharmafile Logo
Pharmafocus logo
Advanced Search
17096650341_abceee54b5_z

Living in polluted city for ten years increases risk of lung disease as much as pack of cigarettes a day for 29 years

August 14, 2019
Research and Development Air pollution, COPD, lung disease, pharma emphysema, public health

Air pollution in cities dramatically increases the risk for and risk of progression of emphysema, a form of chronic obstructive …

News
25482028522_7a08ece5bb_z1

Senate Finance Comittee Chairman, Chuck Grassley calls on Novartis to reveal details of data scandal

August 13, 2019
Research and Development AveXis, Chuck Grassley, Novartis, Zolgensma, sfc

Chuck Grassley, Chairman of the Senate Finance Committee, has demanded that Novartis give up details on the faulty data scandal …

News
shutterstock_114045100

Making things personal: Roche and personalised medicine

August 13, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, feature, personalised medicine, pharma

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to patient …

Feature
shutterstock_360472550

MSD teams up with Harvard University to discover novel immune system pathways to fight cancer

August 13, 2019
Manufacturing and Production, Research and Development Cancer, Harvard, MSD, Merck, immuno-oncology, oncology, pharma

A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use

August 13, 2019
Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma

The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …

News
bacteria-163711_960_720

Chlamydia vaccine proves safe in Phase 1 trial

August 13, 2019
Manufacturing and Production chlamydia, clinicla trials, infectious diseases, pharma, vaccines

A chlamydia vaccine has shown to be safe in a Phase 1 clinical trial, according to a study published in …

News
14712294170_aaaf8f499d_z

Ebola drugs prove 90% effective in clinical trial in DRC

August 13, 2019
Manufacturing and Production, Research and Development Congo, DRC, Ebola, clinical trials, infectious diseases, niaid, pharma

Health professionals in the Democratic Republic of Congo (DRC) are now offering two experimental drugs to people infected with Ebola, …

News
vertex-headquarters

Scotland turns down Vertex’s Orkambi

August 13, 2019
Manufacturing and Production Orkambi, SMC, Scotland, Vertex, cystic fibrosis, pharma

The Scottish Medicines Consortium (SMC) has turned down Vertex’ cystic fibrosis drug Orkambi on the grounds that it is not …

News

Brammer Bio to set up new plant in Norton, Massachusetts

August 12, 2019
Sales and Marketing Brammer Bio, Massachusetts, US, norton, pharma

Cambridge, Massachusetts-based Brammer Bio is planning to set up a new manufacturing facility in Norton, Massachusetts. The Thermo Fisher subsidiary …

News
sag_ebola

FDA-approved drug could be used to treat Ebola, study shows

August 12, 2019
Sales and Marketing Ebolas, FDA, Romark, nitazoxanide, pharma, virus

The FDA-approved anti-parasitic drug nitazoxanide could be used as a treatment for Ebola, according to researchers from the Boston Children’s …

News
28246711066_52e38bc591_z

EU unprepared for no-deal Brexit, health experts warn

August 12, 2019
Sales and Marketing EU, Euroepan Union, UK, brexit, pharma

European health experts have warned that a no-deal Brexit could worsen medicines shortages in the European Union. Speaking to Reuters, …

News

Senators call on FDA to use “forceful response” against Novartis over faulty data scandal

August 12, 2019
Sales and Marketing AveXis, Bernie Sanders, Elizabeth Warren, FDA, Novartis, Zolgensma

Five senators, including presidential candidates Bernie Sanders and Elizabeth Warren, have condemned Novartis for using “falsified data… to obtain approval …

News
amgen_flag

Court sides with Amgen in Sandoz’ challenge over patent on Enbrel

August 12, 2019
Sales and Marketing Enbrel, IP, Novartis Amgen, court, patent, pharma

A US court has sided with Amgen in a legal battle over the patent on blockbuster rheumatoid arthritis drug Enbrel. …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 9, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, CAR T, CAR-T, Eli Lilly, Lexicon, Medicare, Novartis, Pfizer, Sanofi, pharma

This week’s top story covered the scandal surrounding Novartis over its covering up of faulty data from the FDA. The …

News

MS drug boosts effectiveness of cancer therapy in treating glioblastoma, study shows

August 9, 2019
Medical Communications MS, brain cancer, glioblastoma, oncology, pharma

The multiple sclerosis (MS) drug teriflunomide boosts the effectiveness of cancer drugs in treating glioblastoma, according to researchers from UC, …

News
1920px-hiv-budding-color

Scientists use duoCAR-T therapy to fight HIV

August 9, 2019
Medical Communications AIDS, CAR-T therapy, HIV, health, immunotherapy, pharma

Researchers from the University of Pittsburgh, working with the biotech Lentigen, have found that an advanced form of CAR-T therapy …

News
astrazeneca_plaque

AstraZeneca’s Tagrisso improves overall survival in lung cancer in Phase 3 trial

August 9, 2019
Medical Communications AstraZeneca, Cancer, Tagrisso, lung cancer, oncology, pharma

AstraZeneca has said its cancer drug Tagrisso significantly improved overall survival in a Phase 3 study of patients with lung …

News
bayercross3

Bayer buys BlueRock Therapeutics for $600 million

August 9, 2019
Medical Communications Bayer, BlueRock, acquisitions, cell therapies, pharma

Bayer has entered into an agreement to fully acquire engineered cell therapy firm BlueRock Therapeutics in a deal worth $600 …

News
shutterstock_159488225

Transgene terminates oncolytic IO combo trial in advanced liver cancer

August 8, 2019
Research and Development Cancer, Transgene, clinical trials, liver cancer, pharma

Biotech firm Transgene has announced its decision to terminate a study investigating the efficacy of its oncolytic immunotherapy product Pexa-Vec …

News
101817_tumorsmyeloidsuppressorcells

Medicare will cover CAR-T therapies in United States

August 8, 2019
Sales and Marketing CAR-T therapies, Cancer, Gilead, Kymriah, Medicare, Novartis, keytruda, pharma

Medicare will cover the cost of Novartis’ and Gilead’s CAR-T therapies Kymriah and Yescarta, the US Centers for Medicare and …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025